by Suzanne Hayes | Dec 19, 2019 | Blog
When new information regarding the risks and benefits of a product is established after a Pharmacovigilance investigation, it is prudent that changes are made to the safety information of that product. Patient Information Leaflets must be updated for Health Care Professionals and patients in order to use or prescribe the product safely.
by Jackie (née Heneghan) Peck | Dec 19, 2019 | Blog
EMVO announced their office is moving to a new address!
by Jackie (née Heneghan) Peck | Dec 19, 2019 | Blog
When did you last review your QTAs?
Many hours are spent to gain agreement on the finer details
in your agreements as part of the on-boarding and approval process of a supplier or customer and once they are mutually agreed signed and dated by both parties they come into effect.
by Jackie (née Heneghan) Peck | Dec 19, 2019 | Blog
In 2019 many companies were suspended for trading falsified medicines and were victims of fraud.
by Jackie (née Heneghan) Peck | Dec 19, 2019 | Blog
Cannabidiol and Clobazam can be prescribed to treat paediatric patients with seizures associated with Dravets or Lennox-Gastaut syndromes The latest guidance from National Institute for Health and Care Excellence “NICE”
by Ryan Watts | Nov 25, 2019 | Blog
The way the public is influenced is aided by technologies which facilitate messages to be spread at speed, and people trust the medias and or people who deliver the message often without question. They often sign up to follow their newfound friend who is now their trusted expert. People join groups and sign up to blogs and alerts and rarely question the bona fides.